Cargando…
Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry
INTRODUCTION: Ocrelizumab is a monoclonal anti-CD20 antibody approved for the treatment of multiple sclerosis (MS). The clinical value of therapeutic drug monitoring (TDM) for this antibody in treatment of MS is unknown, and an adequately specific and precise quantitation method for ocrelizumab in p...
Autores principales: | Hallin, Erik I., Trætteberg Serkland, Trond, Myhr, Kjell-Morten, Grytten Torkildsen, Øivind, Skrede, Silje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334332/ https://www.ncbi.nlm.nih.gov/pubmed/35910410 http://dx.doi.org/10.1016/j.jmsacl.2022.07.004 |
Ejemplares similares
-
Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS
por: Torkildsen, Øivind, et al.
Publicado: (2014) -
Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014) -
Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014) -
Validation of atovaquone plasma levels by liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring in pediatric patients
por: Horvath, Thomas D., et al.
Publicado: (2022) -
Quantitative analysis of amphiphilic N-alkyloxypyridinecarboximidamide by liquid chromatography–tandem mass spectrometry
por: Wojciechowska, Irmina, et al.
Publicado: (2016)